Search Within

Mikhail Roshal

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (31)
  3. Research Letter (3)
  4. Correspondence (1)
Groups
  1. Department of Pathology and Laboratory Medicine (68)
  2. Epidemiology and Biostatistics (68)
  3. Center for Hematologic Malignancies (66)
  4. Department of Medicine (65)
  5. Hematologic Malignancies, Division of (65)
  6. Biostatistics Service (53)

More Groups

People
  1. Sean Devlin (31)
  2. Sergio Giralt (30)
  3. Maria Arcila (27)
  4. Ahmet Dogan (24)
  5. Ross Levine (24)
  6. Martin Tallman (22)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (9)
  4. 2022 (10)
  5. 2021 (13)
  6. 2020 (8)

More Years

Publications
  1. Blood (30)
  2. Blood Advances (7)
  3. American Journal of Hematology (3)
  4. Leukemia and Lymphoma (3)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Elsevier Inc. (5)
  3. American Association for Cancer Research (4)
  4. Nature Publishing Group (4)
  5. John Wiley & Sons, Inc. (3)
  6. Taylor & Francis Group (3)

More Publishers

Results (68)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chemotherapy signatures reveal the evolutionary history of post-melphalan myeloid neoplasm
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Coffey, D.; Lu, S.; Bolli, N.; Bolton, K.; Park, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Immune escape after allogeneic hematopoietic cell transplantation in pediatric patients with acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Ceglia, N.; Le Luduec, J. B.; McPherson, A.; Spitzer, B.; Bojilova, V.; Panjwani, M. K.; Roshal, M.; Shah, S.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Stem cell autograft minimal residual disease negativity improves outcomes after autotransplant for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Hultcrantz, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save